Table 1 Baseline demographics and patient characteristics
Characteristic | Tapentadol prolonged | Oxycodone controlled |
|---|---|---|
release (n = 978) | release (n = 999) | |
Mean ± SD age, years | 56.8 ± 12.22 | 56.7 ± 12.39 |
Age category, n (%): | ||
<65 years | 719 (73.5) | 731 (73.2) |
≥65 years | 259 (26.5) | 268 (26.8) |
Gender, n (%) | ||
Female | 639 (65.3) | 601 (60.2%) |
Male | 339 (34.7) | 398 (39.8) |
Race, n (%) | ||
White | 803 (82.1) | 813 (81.4) |
Black | 111 (11.3) | 101 (10.1) |
Hispanic | 40 (4.1) | 58 (5.8) |
Other | 24 (2.5) | 27 (2.7) |
Pain condition, n (%) | ||
Osteoarthritis knee pain | 663 (67.8) | 673 (67.4) |
Low back pain | 315 (32.2) | 326 (32.6) |
Mean ± SD pain intensity score *+ | 7.4 ± 1.26 | 7.3 ± 1.21 |
Pain intensity category, n (%) + ~ | ||
Mild | 2 (0.2) | 0 |
Moderate | 119 (12.2) | 123 (12.3) |
Severe | 854 (87.6) | 873 (87.7) |
Prior opioid experience, n (%) | ||
No | 641 (65.5) | 681 (68.2) |
Yes | 337 (34.5) | 318 (31.8) |